Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

NBT Q1 Profit Declines, Yet Beats View By A Penny

NBT Bancorp Inc. (NBTB: Quote), a financial holding company, Monday said its first-quarter profit declined 5 percent to $13.7 million from $14.3 million in the year-ago quarter. On a per share basis, earnings were $0.41, flat with last year.

On average, four analysts polled by Thomson Reuters expected the company to earn $0.40 per share for the first quarter. Analysts' estimates typically exclude special items.

Net-interest income increased slightly to $49.4 million from $49.3 million last year. Non-interest income for the period was $23.1 million, up 14.6 percent from $20.1 million last year.

Net-interest margin was 3.90 percent, down 21 basis points from 4.11 percent last year.

Click here to receive FREE breaking news email alerts for NBT Bancorp Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.